Low Back Pain Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Low Back Pain - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Low Back Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Low Back Pain and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Low Back Pain Overview
  3. Therapeutics Development
  4. Pipeline Products for Low Back Pain - Overview
  5. Pipeline Products for Low Back Pain - Comparative Analysis
  6. Low Back Pain - Therapeutics under Development by Companies
  7. Low Back Pain - Therapeutics under Investigation by Universities/Institutes
  8. Low Back Pain Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Low Back Pain - Products under Development by Companies
  13. Low Back Pain - Products under Investigation by Universities/Institutes
  14. Low Back Pain - Companies Involved in Therapeutics Development
  • Adynxx, Inc.
  • Aestus Therapeutics, Inc.
  • Array BioPharma Inc.
  • Astellas Pharma Inc.
  • Axsome Therapeutics, Inc.
  • Egalet Corporation
  • Frontier Biotechnologies Co., Ltd
  • Gador S.A.
  • Grunenthal GmbH
  • Hisamitsu Pharmaceutical Co., Inc.
  • Immune Pharmaceuticals Inc.
  • Kineta, Inc.
  • MEDRx Co., Ltd.
  • Mesoblast Limited
  • Nektar Therapeutics
  • Orion Oyj
  • Pacira Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Stayble Therapeutics AB

For more information visit http://www.researchandmarkets.com/research/tlndrg/low_back_pain

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Analgesics, Musculoskeletal Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Analgesics, Musculoskeletal Disorders Drugs